183 related articles for article (PubMed ID: 37405123)
21. EWSR1-CREB1 is the predominant gene fusion in angiomatoid fibrous histiocytoma.
Antonescu CR; Dal Cin P; Nafa K; Teot LA; Surti U; Fletcher CD; Ladanyi M
Genes Chromosomes Cancer; 2007 Dec; 46(12):1051-60. PubMed ID: 17724745
[TBL] [Abstract][Full Text] [Related]
22. Expanding the Phenotypic Spectrum of Mesenchymal Tumors Harboring the EWSR1-CREM Fusion.
Yoshida A; Wakai S; Ryo E; Miyata K; Miyazawa M; Yoshida KI; Motoi T; Ogawa C; Iwata S; Kobayashi E; Watanabe SI; Kawai A; Mori T
Am J Surg Pathol; 2019 Dec; 43(12):1622-1630. PubMed ID: 31305268
[TBL] [Abstract][Full Text] [Related]
23. EWS/ETS-Driven Ewing Sarcoma Requires BET Bromodomain Proteins.
Gollavilli PN; Pawar A; Wilder-Romans K; Natesan R; Engelke CG; Dommeti VL; Krishnamurthy PM; Nallasivam A; Apel IJ; Xu T; Qin ZS; Feng FY; Asangani IA
Cancer Res; 2018 Aug; 78(16):4760-4773. PubMed ID: 29898995
[TBL] [Abstract][Full Text] [Related]
24. BET bromodomain inhibitors suppress EWS-FLI1-dependent transcription and the IGF1 autocrine mechanism in Ewing sarcoma.
Loganathan SN; Tang N; Fleming JT; Ma Y; Guo Y; Borinstein SC; Chiang C; Wang J
Oncotarget; 2016 Jul; 7(28):43504-43517. PubMed ID: 27259270
[TBL] [Abstract][Full Text] [Related]
25. EWSR1-CREB1 and EWSR1-ATF1 fusion genes in angiomatoid fibrous histiocytoma.
Rossi S; Szuhai K; Ijszenga M; Tanke HJ; Zanatta L; Sciot R; Fletcher CD; Dei Tos AP; Hogendoorn PC
Clin Cancer Res; 2007 Dec; 13(24):7322-8. PubMed ID: 18094413
[TBL] [Abstract][Full Text] [Related]
26. The melanocyte inducing factor MITF is stably expressed in cell lines from human clear cell sarcoma.
Li KK; Goodall J; Goding CR; Liao SK; Wang CH; Lin YC; Hiraga H; Nojima T; Nagashima K; Schaefer KL; Lee KA
Br J Cancer; 2003 Sep; 89(6):1072-8. PubMed ID: 12966428
[TBL] [Abstract][Full Text] [Related]
27. Primary Pulmonary Myxoid Sarcoma with
Nishimura T; Ii T; Inamori O; Konishi E; Yoshida A
Int J Surg Pathol; 2023 Feb; 31(1):88-91. PubMed ID: 35466725
[TBL] [Abstract][Full Text] [Related]
28. EWSR1-ATF1 fusion is a novel and consistent finding in hyalinizing clear-cell carcinoma of salivary gland.
Antonescu CR; Katabi N; Zhang L; Sung YS; Seethala RR; Jordan RC; Perez-Ordoñez B; Have C; Asa SL; Leong IT; Bradley G; Klieb H; Weinreb I
Genes Chromosomes Cancer; 2011 Jul; 50(7):559-70. PubMed ID: 21484932
[TBL] [Abstract][Full Text] [Related]
29. Molecular diagnosis of clear cell sarcoma: detection of EWS-ATF1 and MITF-M transcripts and histopathological and ultrastructural analysis of 12 cases.
Antonescu CR; Tschernyavsky SJ; Woodruff JM; Jungbluth AA; Brennan MF; Ladanyi M
J Mol Diagn; 2002 Feb; 4(1):44-52. PubMed ID: 11826187
[TBL] [Abstract][Full Text] [Related]
30. Oncogenic MITF dysregulation in clear cell sarcoma: defining the MiT family of human cancers.
Davis IJ; Kim JJ; Ozsolak F; Widlund HR; Rozenblatt-Rosen O; Granter SR; Du J; Fletcher JA; Denny CT; Lessnick SL; Linehan WM; Kung AL; Fisher DE
Cancer Cell; 2006 Jun; 9(6):473-84. PubMed ID: 16766266
[TBL] [Abstract][Full Text] [Related]
31. Targeting the EWS-ETS transcriptional program by BET bromodomain inhibition in Ewing sarcoma.
Hensel T; Giorgi C; Schmidt O; Calzada-Wack J; Neff F; Buch T; Niggli FK; Schäfer BW; Burdach S; Richter GH
Oncotarget; 2016 Jan; 7(2):1451-63. PubMed ID: 26623725
[TBL] [Abstract][Full Text] [Related]
32. Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.
Outani H; Tanaka T; Wakamatsu T; Imura Y; Hamada K; Araki N; Itoh K; Yoshikawa H; Naka N
BMC Cancer; 2014 Jun; 14():455. PubMed ID: 24946937
[TBL] [Abstract][Full Text] [Related]
33. Establishment and Characterization of a Novel Human Clear-cell Sarcoma of Soft-tissue Cell Line, RSAR001, Derived from Pleural Effusion of a Patient with Pleural Dissemination.
Hakozaki M; Tamura H; Dobashi Y; Yoshida A; Kato K; Tajino T; Yamada H; Kaneuchi Y; Katahira K; Ezaki J; Waguri S; Konno S; Watanabe S
Anticancer Res; 2018 Sep; 38(9):5035-5042. PubMed ID: 30194147
[TBL] [Abstract][Full Text] [Related]
34. Myxoid liposarcoma-associated EWSR1-DDIT3 selectively represses osteoblastic and chondrocytic transcription in multipotent mesenchymal cells.
Suzuki K; Matsui Y; Higashimoto M; Kawaguchi Y; Seki S; Motomura H; Hori T; Yahara Y; Kanamori M; Kimura T
PLoS One; 2012; 7(5):e36682. PubMed ID: 22570737
[TBL] [Abstract][Full Text] [Related]
35. Molecular genetic characterization of the EWS/ATF1 fusion gene in clear cell sarcoma of tendons and aponeuroses.
Panagopoulos I; Mertens F; Dêbiec-Rychter M; Isaksson M; Limon J; Kardas I; Domanski HA; Sciot R; Perek D; Crnalic S; Larsson O; Mandahl N
Int J Cancer; 2002 Jun; 99(4):560-7. PubMed ID: 11992546
[TBL] [Abstract][Full Text] [Related]
36. Tumor cell viability in clear cell sarcoma requires DNA binding activity of the EWS/ATF1 fusion protein.
Bosilevac JM; Olsen RJ; Bridge JA; Hinrichs SH
J Biol Chem; 1999 Dec; 274(49):34811-8. PubMed ID: 10574952
[TBL] [Abstract][Full Text] [Related]
37. Clear Cell Carcinoma of Palatal Minor Salivary Gland Harboring a Novel EWSR1-ATF1 Fusion Gene: Report of a Case and Review of the Literature.
Hirose K; Usami Y; Kohara M; Sato S; Iwamoto Y; Murakami S; Uchihashi T; Oya K; Fukuda Y; Hori Y; Morii E; Toyosawa S
Head Neck Pathol; 2021 Jun; 15(2):676-681. PubMed ID: 32816231
[TBL] [Abstract][Full Text] [Related]
38. AT-hook DNA-binding motif-containing protein one knockdown downregulates EWS-FLI1 transcriptional activity in Ewing's sarcoma cells.
Kitagawa T; Kobayashi D; Baron B; Okita H; Miyamoto T; Takai R; Paudel D; Ohta T; Asaoka Y; Tokunaga M; Nakagawa K; Furutani-Seiki M; Araki N; Kuramitsu Y; Kobayashi M
PLoS One; 2022; 17(10):e0269077. PubMed ID: 36194562
[TBL] [Abstract][Full Text] [Related]
39. Selective inhibition of HDAC6 regulates expression of the oncogenic driver EWSR1-FLI1 through the EWSR1 promoter in Ewing sarcoma.
García-Domínguez DJ; Hajji N; Sánchez-Molina S; Figuerola-Bou E; de Pablos RM; Espinosa-Oliva AM; Andrés-León E; Terrón-Camero LC; Flores-Campos R; Pascual-Pasto G; Robles MJ; Machado I; Llombart-Bosch A; Magagnoli G; Scotlandi K; Carcaboso ÁM; Mora J; de Álava E; Hontecillas-Prieto L
Oncogene; 2021 Sep; 40(39):5843-5853. PubMed ID: 34345016
[TBL] [Abstract][Full Text] [Related]
40. Highly active combination of BRD4 antagonist and histone deacetylase inhibitor against human acute myelogenous leukemia cells.
Fiskus W; Sharma S; Qi J; Valenta JA; Schaub LJ; Shah B; Peth K; Portier BP; Rodriguez M; Devaraj SG; Zhan M; Sheng J; Iyer SP; Bradner JE; Bhalla KN
Mol Cancer Ther; 2014 May; 13(5):1142-54. PubMed ID: 24435446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
